ANDVX
Price
$10.21
Change
+$0.12 (+1.19%)
Updated
Jun 6 closing price
Net Assets
488.49M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

ANDVX vs RMEBX

Header iconANDVX vs RMEBX Comparison
Open Charts ANDVX vs RMEBXBanner chart's image
Virtus NFJ Dividend Value R6
Price$10.21
Change+$0.12 (+1.19%)
VolumeN/A
Net Assets488.49M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
ANDVX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ANDVX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANDVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. ANDVX (488M). ANDVX pays higher dividends than RMEBX: ANDVX (1.83) vs RMEBX (1.16). ANDVX was incepted earlier than RMEBX: ANDVX (11 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than ANDVX (0.65). ANDVX is a more actively managed with annual turnover of: 53.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than ANDVX: RMEBX (250) vs ANDVX (2500000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. ANDVX (0.30). RMEBX return over 5 years is better than : 49.85 vs. ANDVX (8.48).
ANDVXRMEBXANDVX / RMEBX
Total Expense Ratio0.651.0761%
Annual Report Gross Expense Ratio0.651.0761%
Fund Existence11 years11 years-
Gain YTD-2.6395.349-49%
Front LoadN/AN/A-
Min. Initial Investment25000002501,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets488M105B0%
Annual Yield % from dividends1.831.16158%
Returns for 1 year0.308.304%
Returns for 3 years-13.4017.96-75%
Returns for 5 years8.4849.8517%
Returns for 10 years-29.0168.21-43%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA